<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR19">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Roussel</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM)</article-title>
  <source>Blood</source>
  <year>2010</year>
  <volume>115</volume>
  <issue>1</issue>
  <fpage>32</fpage>
  <lpage>37</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2009-06-229658</pub-id>
  <?supplied-pmid 19884643?>
  <pub-id pub-id-type="pmid">19884643</pub-id>
 </element-citation>
</ref>
